Hartford HealthCare Endowment
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Feb 15, 2022
Kallyope
|
Series D | $236M | Biotechnology | — |
|
Jan 6, 2022
Eikon Therapeutics
|
Series B | $518M | Biotechnology | — |
|
Jun 16, 2021
Circle Pharma
|
Series C | $66M | Biotechnology | — |
|
Apr 20, 2021
Janux Therapeutics
|
Series B | $125M | Biotechnology | — |
|
Oct 6, 2020
A2 Biotherapeutics
|
Series B | $71.50M | Biotechnology | — |
Hartford HealthCare Endowment has had 3 exits. Hartford HealthCare Endowment most notable exits include Surrozen , Janux Therapeutics
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| Aug 11, 2021 | Surrozen | IPO | Biotechnology | Detail |
| Jun 11, 2021 | Janux Therapeutics | IPO | Biotechnology | Detail |
| Apr 24, 2020 | ORIC Pharmaceuticals | IPO | Biotechnology | Detail |